key: cord-0862254-2xpmlczc
authors: Su, Chia‐Jui; Lee, Chih‐Hung
title: Viral exanthem in COVID‐19, a clinical enigma with biological significance
date: 2020-04-15
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.16469
sha: 9afe6c2f5f6238a0323cb9110c0b2864490e89c8
doc_id: 862254
cord_uid: 2xpmlczc

Since December 2019, the COVID‐19 (1) has spread throughout the world at a staggering speed. As of March 30, 2020, the confirmed case number has reached 693,224 globally and the COVID‐19 has claimed 33,106 lives(2). Current researches emphasize on understanding of transmission patterns, severity, clinical features, and risk factors for infection, but the data remain limited.

and diarrhea (3) . It is not uncommon for viral infections to cause skin rashes, for example, measles, rubella, and dengue fever all cause viral exanthems. However, the prevalence and pattern of cutaneous involvement with COVID-19 are unknown. Guan et al. described 2 (0.2%) patients developed skin rash in the 1,099 patients enrolled (4) . However, the study did not describe the detailed skin manifestation, cutaneous symptoms, timing of the symptom onset or their criteria to diagnose the skin lesions and enrollment into the dataset. Since viral exanthem is not uncommon in viral infections, we were curious about skin manifestations in COVID-19. Meanwhile, we are keen to explore if there is a distinctive cutaneous feature that can help us differentiate coronavirus disease (COVID-19) from other viral infections (5) .

In Italy, COVID-19 has claimed over ten thousand lives, including more than 60 doctors. We (7), whereas viremia of the parvovirus B19 ends before the onset of skin rash (8) . Hence, the dynamic viral load and its reference to skin rash can become a vital clinical clue for the clinicians to determine the optimal timing (before, during, or after the skin rash) to collect the samples for molecular identification.

As we have observed the heavy burden of triage and shortage of essential medical goods posed by the outspread of COVID-19, the introduction of an easy clinical assessment tool like classic COVID-19 skin manifestation is a novel path to cope with the challenge that we are facing during the pandemic. However, this will take more studies to build up the validity and reliability.

Dermatology's outlook in the COVID-19 is multidimensional, starting from the pathogenesis, public health issues to applying new technologies in clinical practice, the opportunities are infinite.

Most importantly, we dermatologists as part of the medical community should contribute our unique perspective in the battle against this formidable pandemic.

A Novel Coronavirus from Patients with Pneumonia in China

WHO (Novel Coronavirus (2019-NCoV) Situation Reports

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical Characteristics of Coronavirus Disease 2019 in China

Role of dermatologists in the uprising of the novel corona virus (COVID-19): Perspectives and opportunities

Cutaneous manifestations in COVID-19: a first perspective

The Immune Response in Measles: Virus Control, Clearance and Protective Immunity

Human parvovirus B19